As new cases of differentiated thyroid cancer become younger and survival rates improve, young and middle-aged patients have become the main population with the disease. Therefore, most patients are in the developmental stage of work. Returning to work after cancer treatment has become common.
Objective
To explore the perceptions and experiences of patients with differentiated thyroid cancer about continuing to work after cancer.
Methods
Using the descriptive phenomenological research method, semi-structured in-depth interviews were conducted with 13 patients with differentiated thyroid cancer who entered the follow-up period, and the data were analyzed using the Colaizzi 7-step analysis method and managed with the help of Nvivo 11.
Results
The themes of work experience are as follows: necessary reasons for continuing to work: survival needs, supporting family, work for recovery; negative effects of disease in work status: distressing cancer symptoms, fear of disease recurrence, difficult choice between health and future, labeling of cancer patients; support and coping: family support, social support, professional information support.
Conclusions
Economic factors play an important role in differentiated thyroid cancer survivors’ choice to continue working. Patients who are currently in a work status have some distress, but to some extent, the work status facilitates survival and treatment. Multidisciplinary and individualized medical interventions, as well as employer and policy support, can help to mitigate the harm caused by cancer diagnosis and treatment and promote patients’ continued work and improved quality of life.
SungHFerlayJSiegelRL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2021; 71: 209–249.
2.
BalochZWAsaSLBarlettaJA, et al.Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol2022; 33: 27–63.
3.
JinSLuoLXuX,et al.Thyroid cancer burden and risk factors in China from 1990–2019: a systematic analysis using the global burden of disease study. Front Oncol2023; 13: 1231636.
4.
KimJGosnellJERomanSA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol2019; 16: 17–29.
5.
SiegelRLMillerKDWagleNS,et al.Cancer statistics, 2023. CA Cancer J Clin2023; 73: 17–48.
6.
CreffGJegouxFBendianeMK, et al.Returning to work by thyroid cancer survivors 5 years after diagnosis: the VICAN survey. J Cancer Surviv2021; 16: 801–811.
7.
RandleRWBushmanNMOrneJ, et al.Papillary thyroid cancer: the good and bad of the “good cancer.”. Thyroid2017; 27: 902–907.
8.
HughesDTReyes-GastelumDKovatchKJ, et al.Energy level and fatigue after surgery for thyroid cancer: a population-based study of patient-reported outcomes. Surgery2020; 167: 102–109.
9.
NeudeckMRSteinertHMoergeliH, et al.Work ability and return to work in thyroid cancer patients and their partners: a pilot study. Psycho-Oncol2016; 26: 556–559.
10.
BrockHFriedrichMSenderA, et al.Work ability and cognitive impairments in young adult cancer patients: associated factors and changes over time—results from the AYA-Leipzig study. J Cancer Surviv2021; 16: 771–780.
11.
MongelliMNGiriSPeipertBJ, et al.Financial burden and quality of life among thyroid cancer survivors. Surgery2020; 167: 631–637.
12.
BüttnerMKroghDSiggelkowH,et al.What are predictors of impaired quality of life in patients with hypoparathyroidism?Clin Endocrinol2022; 97: 268–275.
13.
HastertTABanegasMPHamelLM, et al.Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors. J Cancer Surviv2019; 13: 429–437.
14.
HaddadRIBischoffLBallD, et al.Thyroid carcinoma, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw2022; 20: 925–951.
15.
ChenDWLangBHHMcLeodDSA, et al.Thyroid cancer. The Lancet2023; 401: 1531–1544.
16.
UppalNCunningham (nee Lubitz)CJamesB. The cost and financial burden of thyroid cancer on patients in the US: a review and directions for future research. JAMA Otolaryngol Head Neck Surg2022; 148: 568–575.
17.
DavisSUllmannTMRomanSA. Disparities in treatment for differentiated thyroid cancer. Thyroid2023; 33: 287–293.
18.
LiYZhanYMaoW, et al.Interaction between genetic risks and socioeconomic factors on thyroid cancer: evidence from 0.5 million UK biobank participants. Cancers2023; 15: 5028.
19.
ZhengZHanXZhaoJ, et al.Parental cancer history and its association with minor children's unmet food, housing, and transportation economic needs. JAMA Netw Open2023; 6: e2319359.
20.
TaoWZengZDangH, et al.Towards universal health coverage: achievements and challenges of 10 years of healthcare reform in China. BMJ Glob Health2020; 5: e002087.
21.
LesoVVetraniIDe CiccoL, et al.The impact of thyroid diseases on the working life of patients: a systematic review. Int J Environ Res Public Health2020; 17: 4295.
22.
Ayala-GarciaABenavidesFGSerraL. Labour market participation after sickness absence due to cancer: a dynamic cohort study in Catalonia (Spain). BMC Public Health2023; 23: 2477.
23.
TiedtkeCMBlonkRWBVan RhenenW, et al.Tailored support for preparing employees with cancer to return to work: recognition and gaining new insights in an open atmosphere. Work2023; 76: 1519–1533.
24.
LeeLHYangCIChenMK, et al.Exploring return to work for patients with head and neck cancer. Work2024; 77: 231–241.
25.
SoSCYNgDWLLiaoQ, et al.Return to work and work productivity during the first year after cancer treatment. Front Psychol2022; 13: 866346.
26.
JinJLeeELeeS. Factors associated with distress among female cancer survivors at the workplace: a cross-sectional study. J Occup Health2022; 64: e12364.
27.
SunJHLiYRChangKH, et al.Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: a single-center observational study in Taiwan. Biomed J2022; 45: 923–930.
28.
BogdanovaTRogounovitchTIZurnadzhyL, et al.Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors. Front Endocrinol (Lausanne)2024; 14: 1343848.
29.
LiuYHJinJLiuYJ. Machine learning-based random forest for predicting decreased quality of life in thyroid cancer patients after thyroidectomy. Support Care Cancer2022; 30: 2507–2513.
30.
SawkaAMGhaiSRotsteinL, et al.Gender differences in fears related to low-risk papillary thyroid cancer and its treatment. JAMA Otolaryngol Head Neck Surg2023; 149: 803–810.
31.
NickelBSemsarianCMoynihanR, et al.Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study. BMJ Open2019; 9: e025820.
32.
MarroneJSwarbrickMA. Long-Term unemployment: a social determinant underaddressed within community behavioral health programs. Psychiatr Serv2020; 71: 745–748.
33.
LiebMWünschASchieberK, et al.Return to work after cancer: improved mental health in working cancer survivors. Psychooncology2022; 31: 893–901.
34.
TammingaSJJansenLPFrings-DresenMHW,et al.Long-term employment status and quality of life after cancer: a longitudinal prospective cohort study from diagnosis up to and including 5 years post diagnosis. Work2020; 66: 901–907.
35.
O'NeillCJCarlsonMARoweCW, et al.Hearing the voices of Australian thyroid cancer survivors: qualitative thematic analysis of semistructured interviews identifies unmet support needs. Thyroid2023; 33: 1455–1464.
36.
Dal MasoLSantoroAIannelliE, et al.Cancer cure and consequences on survivorship care: position paper from the Italian alliance against cancer (ACC) survivorship care working group. Cancer Manag Res2022; 14: 3105–3118.
37.
de MoorJSKentEEMcNeelTS, et al.Employment outcomes among cancer survivors in the United States: implications for cancer care delivery. J Natl Cancer Inst2021; 113: 641–644.
38.
Anampa-GuzmánAContreras-ChavezPLustbergMB,et al.Online description of services provided in adult survivorship programs across US accredited cancer centers. J Cancer Surviv2024; 18: 79–83.
39.
PaltrinieriSRicchiEMazziniE, et al.A social-healthcare pathway to facilitate return to work of cancer survivors in Italy: the UNAMANO project. Work2021; 70: 1243–1253.
40.
GordonAJDublinJCPatelE, et al.American Thyroid association guidelines and national trends in management of papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg2022; 148: 1156–1163.
41.
SchlumbergerMLeboulleuxS. Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol2021; 17: 176–188.
42.
HoefsmitNHoukesI. Return to work of employees with low levels of education: the employers’ role and perspective. Work2022; 73: 1189–1202.
43.
StapelfeldtCMMomsenAHJensenAB, et al.Municipal return to work management in cancer survivors: a controlled intervention study. Acta Oncol2021; 60: 370–378.
